Monaco Asset Management Sam Pro Qr Therapeutics N.V. Transaction History
Monaco Asset Management Sam
- $521 Million
- Q2 2025
A detailed history of Monaco Asset Management Sam transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Monaco Asset Management Sam holds 460,000 shares of PRQR stock, worth $1.35 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
460,000
Previous 471,908
2.52%
Holding current value
$1.35 Million
Previous $627,000
49.6%
% of portfolio
0.18%
Previous 0.13%
Shares
12 transactions
Others Institutions Holding PRQR
# of Institutions
64Shares Held
41.2MCall Options Held
26KPut Options Held
0-
Adage Capital Partners Gp, L.L.C. Boston, MA6.6MShares$19.4 Million0.02% of portfolio
-
Privium Fund Management B.V.5MShares$14.7 Million2.17% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.5MShares$10.3 Million1.2% of portfolio
-
Morgan Stanley New York, NY3.08MShares$9.07 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.08MShares$6.1 Million2.02% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $210M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...